The Enterprise Value as of June 2026 (TTM) for Inhibrx Biosciences, Inc. (INBX) is 1.20B

According to Inhibrx Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.20B. This represents a change of 83.13% compared to the average of 653.61M of the last 4 quarters.

Inhibrx Biosciences, Inc. (INBX) Historical Enterprise Value (quarterly & annually)

How has INBX Enterprise Value performed in the past?

The mean historical Enterprise Value of Inhibrx Biosciences, Inc. over the last ten years is 897.01M. The current 1.20B Enterprise Value has changed 13.24% with respect to the historical average. Over the past ten years (40 quarters), INBX's Enterprise Value was at its highest in in the December 2023 quarter at 1.99B. The Enterprise Value was at its lowest in in the June 2024 quarter at -25790079.04.

Inhibrx Biosciences, Inc. (INBX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Inhibrx Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inhibrx Biosciences, Inc. (INBX) Average Enterprise Value

How has INBX Enterprise Value performed in the past?

The current Enterprise Value of Inhibrx Biosciences, Inc. (INBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Inhibrx Biosciences, Inc. (INBX) Enterprise Value vs. Peers

How is INBX’s Enterprise Value compared to its peers?

Inhibrx Biosciences, Inc.’s Enterprise Value is greater than Nektar Therapeutics (1.17B), less than Syndax Pharmaceuticals, Inc. (1.83B), less than Relay Therapeutics, Inc. (2.42B), greater than Amylyx Pharmaceuticals, Inc. (989.29M), less than Enliven Therapeutics, Inc. (2.68B), greater than ORIC Pharmaceuticals, Inc. (799.69M), greater than Immatics N.V. (800.22M), less than Atai Beckley Inc. (1.40B), greater than Sana Biotechnology, Inc. (737.35M), greater than CureVac N.V. (525.58M),

Build a custom stock screener for Inhibrx Biosciences, Inc. (INBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inhibrx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inhibrx Biosciences, Inc. (INBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inhibrx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.